Aas, Inc is awarded a Development Innovation Ventures (DIV) grant from USAID
October 21, 2015
Aas is awarded a DIV grant from USAID to test the commercial viability of a portable molecular diagnostic device as a simple, low-cost alternative for field-based food and agricultural diagnostics and clinical applications in developing countries.​

Aas, Inc recognized in the 2015 NT100 
December 10, 2015
Aas has been recognized in the 2015 NT100 – Nominet Trusts annual celebration of the people and organisations using digital technology to change the world for the better. Discover the #2015NT100 here:  http://bit.ly/1Rz9CND2

Aas becomes distributor for TransGen Biotech and Wizbio
July 30, 2015
Aas is excited to become a distributor for Transgen Biotech and Wizbio Solutions! TransGen Biotech, Inc. is a manufacturer of more than 200 molecular and cellular biology products and kits for life science research and molecular diagnostics. Wizbio is a manufacturer of nucleic acid amplification and molecular diagnostic products.

Aas, Inc. receives a TVP Award from TEDCO
July 8, 2015
Aas has received a Technology Validation Program (TVP) Award from TEDCO to assess its isothermal viral assays.




1450 South Rolling Road

Halethorpe, MD 21227


Aas, Inc.

© 2014 All rights reserved

Solar PCR technology is featured in the Cornell Chronicle and New Scientist

February 21, 2014
Our technology is featured in the Cornell Chronicle and New Scientist.

Dr. Li Jiang and Prof. David Erickson discuss healthcare engineering in LaserFocusWorld

May 2, 2014
Aas Co-Founder Dr. Li Jiang and Prof. David Erickson discuss optofluidics technology and its role in healthcare engineering.

Aas, Inc. is featured on PBS NovaNext
September 17, 2014
The PBS article features technologies that could change the face of healthcare.

Cornell Engineering spotlights Prof. David Erickson, Co-inventor of SolarDx

March 31, 2014
Professor David Erickson explains how his research focuses on creating simple technologies that can perform complex tasks.

Aas, Inc. is awarded a Phase I SBIR from the NCI 
February 11, 2015
Aas is awarded a Phase I grant from the National Cancer Institute to develop its solar-powered point-of-care PCR instrument.